Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

toxic epidermal necrolysis News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A five-year study at a tertiary referral hospital in Somalia provides insights into Stevens-Johnson syndrome and toxic epidermal necrolysis. The research highlights patient demographics, treatment outcomes, and potential triggers for these severe skin conditions.

A new cohort study investigates the prevalence and risk factors associated with epidermal necrolysis sequelae. This research contributes to understanding the long-term impacts of this severe skin condition.

A 10-year retrospective analysis at Chelsea and Westminster Hospital highlights ocular involvement in toxic epidermal necrolysis syndrome. The study reviews current literature, providing insights into the complications associated with this severe skin condition.

A study introduces the NPAR score to enhance prognostic stratification in adults with Stevens-Johnson syndrome and toxic epidermal necrolysis. This addition to the SCORTEN score aims to improve patient outcomes through better risk assessment.

A rare case report details toxic epidermal necrolysis presenting similarly to linear IgA bullous dermatosis without mucosal involvement. This finding may enhance understanding of these conditions and improve diagnostic accuracy.

A 10-year retrospective cohort study at the Royal Brisbane and Women's Hospital provides new insights into Stevens-Johnson syndrome and toxic epidermal necrolysis. The findings may enhance understanding and management of these severe skin conditions.

A systematic review highlights clinical guidelines and consensus statements for the diagnosis and management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in pediatric patients. This review aims to standardize care and improve outcomes for affected children.

Not rare diseases news,news about your rare disease.